Company intelligence
Cerba Research
Transforming Research, Advancing Health Together
About Cerba Research
At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation of human-centric healthcare, by transforming research, and advancing health together. Uniquely, we combine the experience of specialty laboratories with the global reach of a central lab. We have a worldwide network of 1000 labs, hold data from over 85 million patients across five continents, and have the ability to sequence 1000-plus whole human genomes per week. This unparalleled approach to patient data gives you the opportunity to have one partner for all your test services, with consistent access and support across all clinical trial phases.
Verified activity
Signals from Cerba Research
5 published signals
Research & Knowledge
Cerba Research is providing researchers with NGS tools to identify rare variants, monitor tumor evolution, and better understand resistance mechanisms throughout oncology trials.
Reported by Jonathan Caddick PhD MBA
Research & Knowledge
Cerba Research presented an interesting perspective on how robust bioanalytical strategies can help pharma and biotech teams make faster, better-informed development decisions.
Reported by Jonathan Caddick PhD MBA
Presence & Recognition
Cerba Research colleague Matthias De Decker will present a poster at ESCCA 2026 in Salzburg, Austria from 9 to 12 September 2026
Reported by Cerba Research
Presence & Recognition
Cerba Research announced that Matthias De Decker will present a poster at ESCCA 2026 in Salzburg, Austria from 9 to 12 September 2026.
Reported by Cerba Research
Presence & Recognition
Cerba Research is exhibiting at Booth 311 at OPTIONS XIII to discuss influenza, respiratory virus, and vaccine development solutions.
Reported by Sophie E P New